FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

719371003: Atezolizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3316117017 Atezolizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3316118010 Atezolizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49131000195111 atezolizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1119301000241119 atézolizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
63261000195116 Atezolizumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Atezolizumab (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Atezolizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Atezolizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Atezolizumab (substance) Is a Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) true Inferred relationship Some
Atezolizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Programmed cell death protein 1 inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing atezolizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atezolizumab (substance) Inferred relationship Some 1
Product containing atezolizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atezolizumab (substance) Inferred relationship Some 1
Product containing only atezolizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atezolizumab (substance) Inferred relationship Some 1
Atezolizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Atezolizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start